Daniel soffer: ApoA-1 vs HDL-C as Markers of Cardiovascular Risk
Pablo Corral Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared a post on LinkedIn about a recent article by Selin Bilgic et al., published in Journal of Clinical Lipidology, adding:
“ApoA-1 versus HDL-C as markers of cardiovascular risk
HDL-C or ApoA-1:which better reflects cardiovascular risk?
A new analysis from nearly 300,000 UK Biobank participants revisits one of the oldest debates in lipidology:
Key findings:
- ApoA-1 and HDL-C showed similarly strong inverse associations with ASCVD risk
- ApoA-1 explained most of the protective signal traditionally attributed to HDL-C
- Triglycerides contributed far less than expected
- HDL biology may still matter more than many currently assume
Interesting message from this paper:
The story of HDL is probably more nuanced than simply saying ‘HDL is not causal.’
Negative HDL-raising trials did not kill the biology.
They only killed simplistic pharmacology.”
Daniel soffer, Associate Professor of Medicine at University of Pennsylvania, shared this post on LinkedIn:
“Pablo Corral, as usual your posts and commentary are brilliant.
Clearly, HDL is important and clearly, we are measuring what it does poorly.
Manipulating its cholesterol content in serum and even how many HDL particles are in circulation is not the secret.
Perhaps we will figure out how to manipulate HDL for good one day beyond eating healthy, exercising regularly, managing sleep and stress.”
Title: ApoA-1 versus HDL-C as markers of cardiovascular risk
Authors: Selin Bilgic, Karol Pencina, Michael Pencina, Line Dufresne, George Thanassoulis, Allan Sniderman
Stay updated with Hemostasis Today.
-
May 19, 2026, 16:02Stroke Foundation Contributes to National Roundtable on Women’s Cardiovascular Health
-
May 19, 2026, 15:57Explore the Emerging Science Behind Factor XI/XIa Inhibition on the ISTH Academy – ISTH
-
May 19, 2026, 15:55Highlighting Key Achievements and Critical Updates from Iran’s National Blood System – IBTO
-
May 19, 2026, 15:54Joanna Fraser: New Publications on Women and Girls With Inherited Bleeding Disorders
-
May 19, 2026, 15:53Nicolas Hubacz: Hantavirus – What You Should Know
-
May 19, 2026, 15:53John Kowal: AHA/ASA Guidelines for Early Stroke Care Now Include Mobile Stroke Units
-
May 19, 2026, 15:52Cedric Hermans: Proposing a New 3-tier Framework for FVIII Replacement Therapy in Hemophilia A
-
May 19, 2026, 15:46Armghan Ans: Striking Evidence Reversals of The Last Decade for Stroke
-
May 19, 2026, 15:01Laura Girardi: Medical Inpatients’ Thromboprophylaxis – Was It All Already Said?